Recalls / Active ingredient / Bupivacaine
Bupivacaine
2 FDA drug recalls involving the active ingredient “Bupivacaine”.
| Date | Class | Product | Firm |
|---|---|---|---|
| 2022-08-02 | Class III | Zynrelef (bupivacaine and meloxicam), 400 mg bupivacaine and 12 mg meloxicam single dose application, packaged | HERON THERAPEUTICS, INC. |
| 2019-11-21 | Class II | EXPAREL, Bupivicaine Liposome Injectable Suspension, 1.3%, 266 mg/20 mL (13 mg/mL), Sterile, 20 mL vial, Rx on | Pacira Pharmaceuticals, Inc. |